| PERIOD ENDING | 30-Apr-09 | 30-Apr-08 | 30-Apr-07 | | Total Revenue | 108,651 | 62,017 | 58,898 | | Cost of Revenue | 56,971 | 40,505 | 35,704 | | | Gross Profit | 51,680 | 21,512 | 23,194 | | | Operating Expenses | | Research Development | 7,429 | 6,208 | 4,733 | | Selling General and Administrative | 33,292 | 22,625 | 23,914 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 10,959 | (7,321) | (5,453) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,928 | 480 | 1,437 | | Earnings Before Interest And Taxes | 15,887 | (6,841) | (4,016) | | Interest Expense | 38 | 27 | 18 | | Income Before Tax | 15,849 | (6,868) | (4,034) | | Income Tax Expense | 6,032 | (1,770) | (1,998) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,817 | (5,098) | (2,036) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,817 | (5,098) | (2,036) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,817 | ($5,098) | ($2,036) |
|
1.48% Nasdaq 
Income Statement
